View More View Less
  • 1 Chinese Academy of Sciences Radiopharmaceutical Research Center, Shanghai Institute of Nuclear Research P.O. Box 800-204 Shanghai 201800 P.R. China
  • 2 University of Fudan Shanghai Department of Nuclear Medicine , Hua-shang Hospital 201800 P.R. China
Restricted access

Abstract  

The compound 3-{[4-(4-[18F]fluorophenyl)methyl]piperazin-1-yl}-methyl-1H-pyrrolo[2,3-b]pyridine ([18F]3), which is an analogue of L-745,870 binding D4